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This dataset report is dedicated to mitochondrial genome variants
associated with asymptomatic atherosclerosis. These data were
obtained using the method of next generation pyrosequencing
(NGPS). The whole mitochondrial genome of the sample of
patients from the Moscow region was analyzed. In this article the
dataset including anthropometric, biochemical and clinical para-
meters along with detected mtDNA variants in patients with car-
otid atherosclerosis and healthy individuals was presented. Among
58 of the most common homoplasmic mtDNA variants found in
the observed sample, 7 variants occurred more often in patients
with atherosclerosis and 16 variants occurred more often in
healthy individuals.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
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Dubject area Genetics, Molecular genetics
ore speciﬁc sub-
ject areaAtherosclerosisype of data Sequencing data
ow data was
acquiredRoche 454 GS Junior Titaniumata format Raw, analysed
xperimental
factorsUltrasound scanning of carotid arteries; extraction of DNA from blood leucocytes
of patients; enrichment of mitochondrial genome by the ampliﬁcation of whole
mitochondrial genome; sequencing of mtDNAxperimental
featuresWe performed next generation pyrosequencing of whole mitochondrial genome
of the sample of patients from the Moscow region with carotid atherosclerosis
and control subjects without atherosclerosis. mtDNA variants were characterized
by the occurrence in the compared groups.ata source
locationMoscow, Russian Federationata accessibility Data is with this article.D
Value of the data
 The data of next generation pyrosequencing of whole mitochondrial genome let us ﬁnd homo-
plasmic variants associated with atherosclerotic lesions of carotid arteries in patients from the
Moscow regionwith atherosclerosis and subjects without atherosclerotic lesions of carotid arteries.
 mtDNA sequencing data was obtained using Roche 454 GS Junior Titanium system.
 The data of statistical analysis was obtained using IBM SPSS Statistics v.21.0.
 The data helps to detect new genetic markers of individual predisposition to asymptomatic
atherosclerosis in humans.1. Data
The relevant data is provided in this article. See Table 1 and Table 1, and Figs. 1 and 2. The raw data ﬁles
(fastq ﬁles) that were used in the analysis and interpretation are available in Institute for Atherosclerosis
Research, Skolkovo Innovative Center, Moscow Region, Russian Federation. http://inat.ru/.2. Experimental design, materials and methods
This dataset report is dedicated to mtDNA variants, associated with asymptomatic atherosclerosis.
These data were obtained using the method of next generation pyrosequencing (NGPS). The whole
mitochondrial genome of the sample of patients from the Moscow region was analyzed.
In this article the dataset of homoplasmic mtDNA variants in patients with atherosclerosis and
healthy individuals from the Moscow region was presented (Table 1 and Table 1, Figs. 1 and 2).2.1. Materials
The materials for obtaining the data were leukocytes from whole blood of 68 patients. 31 subjects
with carotid atherosclerosis and 37 control subjects without atherosclerosis were selected for the
study [1–5] (Table 1).
Table 1
The most common homoplasmic mtDNA variants in the observed sample.
mtDNA variant Gene/region Character of mutationa % of cases
General Controls Atherosclerotic patients
m.73A4G Noncoding – 51.5 51.6 51.4
m.146T4C Noncoding – 7.4 6.5 8.1
m.152T4C Noncoding – 14.7 19.4 10.8
m.185G4A Noncoding – 5.9 6.5 5.4
m.195T4C Noncoding – 14.7 22.6 8.1
m.204T4C Noncoding – 5.9 3.2 8.1
m.228G4A Noncoding – 5.9 3.2 8.1
m.263A4G Noncoding – 91.2 87.1 94.6
m.489T4C Noncoding – 7.4 6.5 8.1
m.709G4A RNR1 – 14.7 19.4 10.8
m.750A4G RNR1 – 86.8 83.9 89.2
m.930G4A RNR1 – 7.4 6.5 8.1
m.1438A4G RNR1 – 83.8 83.9 83.8
m.1719G4A RNR2 – 5.9 0.0 10.8
m.1811A4G RNR2 – 13.2 12.9 13.5
m.1888G4A RNR2 – 11.8 12.9 10.8
m.2706A4G RNR2 – 50.0 45.2 54.1
m.3010G4A RNR2 – 20.6 16.1 24.3
m.3107delN RNR2 – 89.7 83.9 94.6
m.4216T4C ND1 m 20.6 22.6 18.9
m.4769A4G ND2 s 85.3 77.4 91.9
m.4917A4G ND2 m 14.7 16.1 13.5
m.5147G4A ND2 s 8.8 9.7 8.1
m.7028C4T COX1 s 48.5 48.4 48.6
m.8251G4A COX2 s 7.4 3.2 10.8
m.8697G4A ATP6 s 13.2 16.1 10.8
m.8860A4G ATP6 m 92.6 90.3 94.6
m.10398A4G ND3 m 16.2 19.4 13.5
m.10463T4C TRNR – 14.7 16.1 13.5
m.11251A4G ND4 s 19.1 22.6 16.2
m.11467A4G ND4 s 19.1 19.4 18.9
m.11719G4A ND4 s 50.0 51.6 48.6
m.11812A4G ND4 s 10.3 9.7 10.8
m.12308A4G TRNL2 – 20.6 22.6 18.9
m.12372G4A ND5 s 20.6 22.6 18.9
m.12612A4G ND5 s 8.8 9.7 8.1
m.12705C4T ND5 s 5.9 3.2 8.1
m.13368G4A ND5 s 14.7 16.1 13.5
m.13708G4A ND5 m 11.8 16.1 8.1
m.14233A4G ND6 s 11.8 9.7 13.5
m.14766C4T CYTB m 45.6 48.4 43.2
m.14798T4C CYTB m 8.8 12.9 5.4
m.14905G4A CYTB s 14.7 16.1 13.5
m.15326A4G CYTB m 89.7 87.1 91.9
m.15452C4A CYTB m 22.1 25.8 18.9
m.15607A4G CYTB s 11.8 12.9 10.8
m.15784T4C CYTB s 4.4 9.7 0.0
m.15928G4A TRNT – 11.8 12.9 10.8
m.16069C4T Noncoding – 10.3 12.9 8.1
m.16126T4C Noncoding – 23.5 29.0 18.9
m.16145G4A Noncoding – 5.9 6.5 5.4
m.16223C4T Noncoding – 7.4 3.2 10.8
m.16256C4T Noncoding – 7.4 12.9 2.7
m.16294C4T Noncoding – 14.7 19.4 10.8
m.16296C4T Noncoding – 8.8 9.7 8.1
m.16304T4C Noncoding – 11.8 9.7 13.5
m.16311T4C Noncoding – 10.3 6.5 13.5
m.16519T4C Noncoding – 51.5 51.6 51.4
a For mutations in protein coding genes: m – missense, s – synonymous.
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Fig. 2. The most common mtDNA variants that were more frequent (with ratio 4¼1.5) in atherosclerotic patients compared
with controls. For positions in coding region, names of genes are given in brackets.
Fig. 1. The most common mtDNA variants that were more frequent (with ratio 4¼1.5) in controls compared with athero-
sclerotic patients. For positions in coding region, names of genes are given in brackets.
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diseases. The number of patients with diabetes mellitus was minimized (3 subjects among the
sample).
2.2. Methods
To assess the state of the carotid artery wall, high-resolution B-mode ultrasonography was per-
formed with ultrasound scanner SonoScape SSI-1000 (China) using a linear vascular 7.5 MHz sensor.
Values of the average carotid intima-medial thickness (CIMT) were used to estimate the presence and
severity of atherosclerotic plaques in carotid arteries (Table 1). Borderline age-related CIMT values for
Moscow region population were used to characterize the presence of carotid atherosclerosis [6]. If
there was a presence of atherosclerotic plaque with the carotid artery stenosis of more than 20% or
thickening of the intima-media layer exceeding the boundaries of the 75th percentile, as well as the
combination of these factors, persons were considered as belonging to the group of patients with
atherosclerosis. Controls were characterized by CIMT values that does not exceed median values for
M.A. Sazonova et al. / Data in Brief 7 (2016) 1570–15751574appropriate age group, and by the absence of atherosclerotic plaques (for some persons – the pre-
sence of carotid stenosis that does not exceed 20%).
The extraction of DNA from blood leukocytes of patients was performed using methods developed
earlier by us [7–9], on the basis of the methods, published by Maniatis et al. [10,11]. Before
sequencing, an enrichment of mitochondrial genome by the ampliﬁcation of the whole mitochondrial
genome using REPLI-g Mitochondrial Kit (Qiagen, Germany) was performed. To carry out mtDNA
sequencing, Roche 454 GS Junior Titanium system (Roche Applied Science, USA) was used. Sequen-
cing workﬂow was performed according to the manufacturer's recommendations and using appro-
priate instruments and reagents.
Sequence analysis of mitochondrial DNA was carried out using GS Reference Mapper software
(Roche Applied Science, USA). Cambridge reference sequence of the human mitochondrial genome
(rCRS, NC_012920.1) was used for mapping [12]. Statistical analysis of the obtained data was carried
out using IBM SPSS Statistics v.21.0.
2.3. Data obtained with the use of NGPS
We identiﬁed 58 most common homoplasmic variants that were characterized by more than 5%
presence in the observed sample (Table 1). Among them, 7 mtDNA variants were associated with
presence of atherosclerotic lesions of carotid arteries (204C, 228A, 1719A, 3010A, 8251A, 12705T,
16223T) (Fig. 1) and 16 variants mtDNA occurred more often in healthy individuals (152T, 195C, 263A,
709A, 750A, 4769A, 8697A, 8860A, 13708A, 14798C, 15326A, 15784С, 16069T, 16126C, 16256T, 16294T)
(Fig. 2).Acknowledgments
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